Evidence map›Paper›PMID 22642931›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2012

Stent elution rate determines drug deposition and receptor-mediated effects.

Abraham R Tzafriri, Adam Groothuis, G Sylvester Price, Elazer R Edelman

Open access · bronzeAbstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Endovascular Drug Delivery.Life (Basel, Switzerland) · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.Journal of the American College of Cardiology · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  14. Article
  15. Review
  16. Position Paper Computational Cardiology.IEEE journal of biomedical and health informatics · 2019
    Article
  17. Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  18. Article
  19. Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Abraham R TzafririDepartment of Science Services, CBSET Inc., Lexington, MA 02421, USA. rtzafriri@cbset.org
Adam Groothuis
G Sylvester Price
Elazer R Edelman
Society for Science & the Public · USHarvard University · USJohnson & Johnson (United States) · US

Funding

Vascular Drug Delivery - Supplement for EquipmentR01GM049039 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI EDELMAN, ELAZER R · 1994 to 2019
$8.9M
NIGMS NIH HHS R01 GM049039NIGMS NIH HHS R01 GM-49039
6 · The paper itself

Abstract

Drug eluting stent designs abound and yet the dependence of efficacy on drug dose and elution duration remains unclear. We examined these issues within a mathematical framework of arterial drug distribution and receptor binding following stent elution. Model predictions that tissue content linearly tracks stent elution rate were validated in porcine coronary artery sirolimus-eluting stents implants. Arterial content varied for stent types, progressively declining from its Day 1 peak and tracking with rate-limiting drug elution--near zero-order release was three-fold more efficient at depositing drug in the stented lesion than near first-order release. In vivo data were consistent with an overabundance of non-specific sirolimus-binding sites relative to the specific receptors and to the delivered dose. The implication is that the persistence time of receptor saturation and effect is more sensitive to duration of elution than to eluted amount. Consequently, the eluted amount should be sufficiently high to saturate receptors at the target lesion, but dose escalation alone is an inefficient strategy for prolonging the duration of sirolimus deposition. Moreover, receptor saturating drug doses are predicted to be most efficacious when eluted from stents in a constant zero order fashion as this maximizes the duration of elution and receptor saturation.

Indexed as

Drug-Eluting StentsModels, BiologicalAnimalsCoronary VesselsImmunosuppressive AgentsSirolimusSwineImmunosuppressive AgentsSirolimus

Identifiers

PMID22642931
PMCPMC3616625
OpenAlexW2156557177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.